On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?

In 2025, the Biomedical mergers and acquisitions will begin.

wallstreetcn19:01

Trump Looms Large Over Stock Markets. Why Chips, -2-

Barron's17minutes ago

BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Futu News18:38 · Ratings

Express News | Trellus Health - Entered Deal With Johnson & Johnson Health Care Systems to Support Pilot in US to Assess Potential for Trellus Elevate Program

Breakings15:07

Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Futu News09:31 · Ratings

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal -- Update

WSJ04:12